Lise Werner
About
Lise Werner is a scholar working on Infectious Diseases, Virology and Epidemiology.
According to data from OpenAlex, Lise Werner has authored 63 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Infectious Diseases, 33 papers in Virology and 28 papers in Epidemiology. Recurrent topics in Lise Werner's work include HIV Research and Treatment (33 papers), HIV/AIDS Research and Interventions (29 papers) and Reproductive tract infections research (14 papers). Lise Werner is often cited by papers focused on HIV Research and Treatment (33 papers), HIV/AIDS Research and Interventions (29 papers) and Reproductive tract infections research (14 papers). Lise Werner collaborates with scholars based in South Africa, United States and United Kingdom. Lise Werner's co-authors include Salim S. Abdool Karim, Koleka Mlisana, Quarraisha Abdool Karim, Carolyn Williamson, Angela D. M. Kashuba, Nesri Padayatchi, Max R. O’Donnell, Thumbi Ndung’u, Jo‐Ann S. Passmore and Francois van Loggerenberg and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Annals of Internal Medicine.
In The Last Decade
Lise Werner
63 papers receiving 2.4k citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Lise Werner South Africa | 26 | 1.4k | 954 | 929 | 592 | 490 | 63 | 2.4k | ||
| Jorge del Romero Spain | 34 | 2.2k 1.5× | 1.6k 1.7× | 1.5k 1.6× | 397 0.7× | 166 0.3× | 144 | 3.7k | ||
| Leonard Maboko Germany | 28 | 1.5k 1.0× | 948 1.0× | 799 0.9× | 444 0.8× | 183 0.4× | 71 | 2.5k | ||
| Raman Gangakhedkar India | 25 | 1.4k 0.9× | 978 1.0× | 548 0.6× | 168 0.3× | 272 0.6× | 106 | 2.4k | ||
| Julie Overbaugh United States | 32 | 2.2k 1.6× | 1.2k 1.3× | 2.0k 2.2× | 530 0.9× | 268 0.5× | 72 | 3.3k | ||
| Job Bwayo Kenya | 14 | 678 0.5× | 777 0.8× | 434 0.5× | 299 0.5× | 754 1.5× | 17 | 1.8k | ||
| J Kreiss United States | 21 | 1.3k 0.9× | 707 0.7× | 815 0.9× | 324 0.5× | 634 1.3× | 29 | 2.4k | ||
| R. Scott McClelland United States | 31 | 1.4k 1.0× | 1.2k 1.2× | 623 0.7× | 252 0.4× | 1.1k 2.2× | 100 | 3.0k | ||
| Bhavna Chohan United States | 30 | 1.9k 1.3× | 1.3k 1.4× | 1.5k 1.6× | 488 0.8× | 1.2k 2.5× | 90 | 3.8k | ||
| Rosemary Musonda United States | 32 | 2.8k 2.0× | 1.4k 1.5× | 1.7k 1.8× | 619 1.0× | 274 0.6× | 91 | 4.5k | ||
| Frank Plummer Canada | 30 | 1.7k 1.2× | 1.0k 1.1× | 429 0.5× | 391 0.7× | 857 1.7× | 57 | 3.4k |
Countries citing papers authored by Lise Werner
Since
Specialization
Citations
This map shows the geographic impact of Lise Werner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lise Werner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lise Werner more than expected).
Fields of papers citing papers by Lise Werner
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Lise Werner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lise Werner. The network helps show where Lise Werner may publish in the future.
Co-authorship network of co-authors of Lise Werner
This figure shows the co-authorship network connecting the top 25 collaborators of Lise Werner. A scholar is included among the top collaborators of Lise Werner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lise Werner. Lise Werner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Kharsany, Ayesha B. M., Zizipho Z. A. Mbulawa, Vivek Naranbhai, et al.. (2016). High Burden of Human Papillomavirus (HPV) Infection among Young Women in KwaZulu-Natal, South Africa. PLoS ONE. 11(1). e0146603–e0146603.
2.
O’Donnell, Max R., Melendhran Pillay, Manormoney Pillay, et al.. (2015). Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 69(5). 536–543.
3.
Kashuba, Angela D. M., Tanuja N. Gengiah, Lise Werner, et al.. (2015). Genital Tenofovir Concentrations Correlate With Protection Against HIV Infection in the CAPRISA 004 Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 69(3). 264–269.
4.
Naicker, Nivashnee, Ayesha B. M. Kharsany, Lise Werner, et al.. (2015). Risk Factors for HIV Acquisition in High Risk Women in a Generalised Epidemic Setting. AIDS and Behavior. 19(7). 1305–1316.
5.
Karim, Quarraisha Abdool, Rachael Dellar, Benjamin Bearnot, et al.. (2015). HIV-Positive Status Disclosure in Patients in Care in Rural South Africa: Implications for Scaling Up Treatment and Prevention Interventions. AIDS and Behavior. 19(2). 322–329.
6.
Karim, Salim S. Abdool, Quarraisha Abdool Karim, Ayesha B. M. Kharsany, et al.. (2015). Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection. New England Journal of Medicine. 373(6). 530–539.
7.
O’Donnell, Max R., Allison Wolf, Lise Werner, C. Robert Horsburgh, & Nesri Padayatchi. (2014). Adherence in the Treatment of Patients With Extensively Drug-Resistant Tuberculosis and HIV in South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(1). 22–29.
8.
Richardson, Simone I., Elin S. Gray, Nonhlanhla N. Mkhize, et al.. (2014). The Sequence of the α4β7-binding Motif on Gp120 of Transmitted/Founder Viruses Contributes to the Dependence on the Integrin for HIV Infection. AIDS Research and Human Retroviruses. 30(S1). A56–A56.
9.
Dellar, Rachael, Quarraisha Abdool Karim, Leila E. Mansoor, et al.. (2014). The Preventive Misconception: Experiences from CAPRISA 004. AIDS and Behavior. 18(9). 1746–1752.
10.
Wei, Xierong, Gillian Hunt, Salim S. Abdool Karim, et al.. (2014). Sensitive Tenofovir Resistance Screening of HIV-1 From the Genital and Blood Compartments of Women With Breakthrough Infections in the CAPRISA 004 Tenofovir Gel Trial. The Journal of Infectious Diseases. 209(12). 1916–1920.
11.
Padayatchi, Nesri, et al.. (2014). Clofazimine in the treatment of extensively drug-resistant tuberculosis with HIV coinfection in South Africa: a retrospective cohort study. Journal of Antimicrobial Chemotherapy. 69(11). 3103–3107.
12.
O’Donnell, Max R., Nesri Padayatchi, Charlotte Kvasnovsky, et al.. (2013). Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infection. Emerging infectious diseases. 19(3). 416–424.
13.
Mlisana, Koleka, Nivashnee Naicker, Lise Werner, et al.. (2012). Symptomatic Vaginal Discharge Is a Poor Predictor of Sexually Transmitted Infections and Genital Tract Inflammation in High-Risk Women in South Africa. The Journal of Infectious Diseases. 206(1). 6–14.
14.
Valley‐Omar, Ziyaad, Sengeziwe Sibeko, Jeffrey A. Anderson, et al.. (2012). CAPRISA 004 Tenofovir Microbicide Trial: No Impact of Tenofovir Gel on the HIV Transmission Bottleneck. The Journal of Infectious Diseases. 206(1). 35–40.
15.
Mureithi, Marianne, Danielle N. Poole, Vivek Naranbhai, et al.. (2012). Preservation HIV-1–Specific IFNγ+ CD4+ T-Cell Responses in Breakthrough Infections After Exposure to Tenofovir Gel in the CAPRISA 004 Microbicide Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 60(2). 124–127.
16.
Ramsuran, Veron, Hemant Kulkarni, Weijing He, et al.. (2011). Duffy-Null–Associated Low Neutrophil Counts Influence HIV-1 Susceptibility in High-Risk South African Black Women. Clinical Infectious Diseases. 52(10). 1248–1256.
17.
O’Donnell, Max R., Jennifer Zelnick, Lise Werner, et al.. (2011). Extensively Drug-Resistant Tuberculosis in Women, KwaZulu-Natal, South Africa. Emerging infectious diseases.
18.
O’Donnell, Max R., Jennifer Zelnick, Lise Werner, et al.. (2011). Extensively Drug-Resistant Tuberculosis in Women, KwaZulu-Natal, South Africa. Emerging infectious diseases. 17(10). 1942–1945.
19.
Werner, Lise, et al.. (2009). Interleukin‐10 Promoter Polymorphisms Influence HIV‐1 Susceptibility and Primary HIV‐1 Pathogenesis. The Journal of Infectious Diseases. 200(3). 448–452.
20.
Reddy, Kavidha, Cheryl A. Winkler, Lise Werner, et al.. (2009). APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load. AIDS. 24(2). 195–204.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jorge del Romero Breakdown of academic impact, for papers by Leonard Maboko Breakdown of academic impact, for papers by Raman Gangakhedkar Breakdown of academic impact, for papers by Julie Overbaugh Breakdown of academic impact, for papers by Job Bwayo Breakdown of academic impact, for papers by J Kreiss Breakdown of academic impact, for papers by R. Scott McClelland Breakdown of academic impact, for papers by Bhavna Chohan Breakdown of academic impact, for papers by Rosemary Musonda Breakdown of academic impact, for papers by Frank Plummer